NOI to Sole Source PhysioMimix Organ-on-a-Chip systems
Inactive on SAM.gov — responses were due 5 May 2026 · No Set aside used · Defense Health Agency (DHA), DoD · Frederick, MD · NAICS 334516 · Solicitation HT942626QE019
Following NAICS 334516? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 05 May 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
This one has closed. We'll email you when new NAICS 334516 (Analytical Laboratory Instrument Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
The Defense Health Agency Contracting Activity (DHACA) intends to award a Firm Fixed Price, sole source Indefinite Delivery Indefinite Quantity (IDIQ) contract, on behalf of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), to CN Bio Innovations Limited, under the authority of 41 USC 1901, as implemented in Revolutionary FAR Overhaul (RFO) 12.102 -- Restricting competition and RFO 12.201-1 Simplified procedures. This requirement is for the delivery of PhysioMimix Organ-on-a-Chip systems and associated consumables/components compatible with the existing PhysioMimix systems currently in place at USAMRIID. While similar equipment and consumables may be available from other vendors, the other PhysioMimix systems in the market require the use of proprietary consumables that are not compatible with other transwell based organoid models including the CN Bio PhysioMimix systems currently in use at USAMRIID. CN Bio Innovations Limited is the only vendor capable of providing transwell based organoid models meeting the Government s minimum essential characteristics and being compatible with the existing CN Bio PhysioMimix systems in use at USAMRIID. This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these supplies. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the government not to compete based on responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement. Capability statements are due no later than 1000 Eastern Time, 05 May 2026. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email addresses: grant.a.gratton.civ@health.mil and jayme.l.fletcher2.civ@health.mil. No phone calls will be accepted.
Go deeper on this solicitation
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
